HomeProductsBioactive CompoundsGPCR & G Protein TargetsGlucagon ReceptorLgd-6972
Chemical structure of CAS 1207989-09-0

Lgd-6972

CAS No.1207989-09-0
MDL No.MFCD28411370
MFC43H46N2O5S
MW702.90
InChI KeyHKJMCBYPVCGZFB-LDLOPFEMSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1207989-09-0
Product NameLgd-6972

Associated Conditions

type 2 diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Efficacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study.

Diabetes care • Vol. 43, Issue 1 • 2020
PMID: 31694861DOI: 10.2337/dc19-1328

Pharmacokinetics and pharmacodynamics of single and multiple doses of the glucagon receptor antagonist LGD-6972 in healthy subjects and subjects with type 2 diabetes mellitus.

Diabetes, obesity & metabolism • Vol. 19, Issue 1 • 2017
PMID: 27501510PMC: PMC5215471DOI: 10.1111/dom.12752

Documentation